Labcorp EBITDA 2010-2024 | LH

Labcorp EBITDA for the quarter ending June 30, 2024 was $0.452B, a 10.39% increase year-over-year.

  • Labcorp 2023 EBITDA was 1.303B, a 33.99% decline from 2022.
  • Labcorp 2022 EBITDA was 1.974B, a 45.56% decline from 2021.
  • Labcorp 2021 EBITDA was 3.626B, a 2.64% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Labcorp EBITDA 2010-2024 | LH

  • Labcorp 2023 EBITDA was 1.303B, a 33.99% decline from 2022.
  • Labcorp 2022 EBITDA was 1.974B, a 45.56% decline from 2021.
  • Labcorp 2021 EBITDA was 3.626B, a 2.64% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$66.8B
McKesson (MCK)$66.6B
Cardinal Health (CAH)$26.9B
Cooper (COO)$21.9B
West Pharmaceutical Services (WST)$21.5B
Align Technology (ALGN)$18.9B
Henry Schein (HSIC)$9B
Merit Medical Systems (MMSI)$5.7B
DENTSPLY SIRONA (XRAY)$5.4B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.6B
Lifevantage (LFVN)$125M
Pro-Dex (PDEX)$83M